EarthOptics
Venture Round in 2024
EarthOptics is a company focused on sustainable agricultural management through the development of a global soil cloud platform. Utilizing advanced sensors and machine learning, EarthOptics creates highly accurate soil maps by analyzing far fewer soil samples. The platform provides detailed insights into various soil attributes, including compaction, fertility, and carbon levels. This technology empowers farmers, ranchers, and land managers to make informed decisions that enhance profitability and sustainability in soil management. Additionally, EarthOptics offers near-real-time actionable data that aids in monitoring soil health, benefiting both agricultural practices and carbon credit verification efforts.
EarthOptics
Series B in 2023
EarthOptics is a company focused on sustainable agricultural management through the development of a global soil cloud platform. Utilizing advanced sensors and machine learning, EarthOptics creates highly accurate soil maps by analyzing far fewer soil samples. The platform provides detailed insights into various soil attributes, including compaction, fertility, and carbon levels. This technology empowers farmers, ranchers, and land managers to make informed decisions that enhance profitability and sustainability in soil management. Additionally, EarthOptics offers near-real-time actionable data that aids in monitoring soil health, benefiting both agricultural practices and carbon credit verification efforts.
BIOHM Health
Seed Round in 2023
BIOHM Health is a pioneering company in the field of microbiome research, focusing on the role of fungi in digestive health. Founded by Dr. Mahmoud Ghannoum, who has conducted over 20 years of NIH-supported research, BIOHM offers whole probiotics and gut microbiome testing kits. The company's innovative approach targets digestive plaque, a destructive film formed by bad bacteria and fungi that disrupts the natural balance of the digestive system. BIOHM's dual-action technology breaks down this plaque and neutralizes harmful microorganisms, promoting optimal digestive health. Their products provide consumers with insights into their gut health and personalized recommendations for diet, lifestyle, and supplements to support overall well-being.
ModifyHealth
Series B in 2023
ModifyHealth is a digital health platform focused on improving outcomes and reducing costs for individuals with chronic conditions such as diabetes, heart disease, kidney disease, irritable bowel syndrome, and related gastrointestinal issues. The company offers a meal delivery service that provides fully-prepared, nutritious meals tailored to support those with chronic health conditions, including gluten-free and low-FODMAP options. In addition to meal delivery, ModifyHealth provides dietitian coaching and remote patient monitoring to ensure sustained benefits and personalized support for better health management.
Veracity Verification Solutions
Seed Round in 2022
Veracity Verification Solutions is a developer of verification software aimed at connecting educational technology (EdTech) providers with educators. The company offers a transparent, merit-based verification system that assists school systems in identifying reliable software services. By verifying the performance and specifications of various EdTech products, Veracity helps educational institutions avoid misleading marketing practices and unreliable reviews. This enables schools to make informed decisions based on unbiased evaluations, ensuring that they select tools that genuinely meet their needs and enhance the educational experience.
Discure
Seed Round in 2022
Discure Technologies is focused on developing a minimally invasive, implantable bioelectronic device aimed at treating degenerative disc disease (DDD). The company employs a novel bioelectric technique that targets the root causes of DDD, facilitating the healing of damaged discs, alleviating pain, and restoring normal function for patients. Through its innovative approach, Discure seeks to provide effective solutions for individuals suffering from this debilitating condition.